Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease
Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1966-1969
DOI: 10.1002/ccd.70566 ↗At a glance
Fallbericht in Catheterization and Cardiovascular Interventions, published online on 2026-03-22. Written by Rohit B Ponnada and 10 co-authors. Institution: Saint Louis University School of Medicine, St. Louis, Missouri, USA. Major MEDLINE topics: Peripheral Arterial Disease, Heart-Assist Devices, Percutaneous Coronary Intervention, Non-ST Elevated Myocardial Infarction. 11 references. Funded by: American Heart Association.
Abstract (original language)
Mechanical circulatory support (MCS) devices can be helpful to maintain hemodynamic stability during high‐risk percutaneous coronary intervention (PCI). Iliofemoral arterial disease limits the use of transfemoral MCS devices. Impella 5.5, a surgical transaxillary MCS device, represents a viable option for MCS‐protected PCI. We report a 74‐year‐old man with prior endovascular aneurysm repair (EVAR), severe peripheral artery disease (PAD), and newly diagnosed NSTEMI was found to have three‐vessel and left main coronary disease with an ejection fraction (EF) of 13%. Due to aortoiliac occlusion, transfemoral MCS was not feasible. Instead, an Impella 5.5 was implanted via a right axillary artery graft, enabling successful orbital atherectomy and bifurcation PCI. In summary, axillary Impella 5.5 insertion is a viable option in anatomically complex patients where femoral access is contraindicated. This approach allows full left ventricular hemodynamic support for revascularization in otherwise inoperable patients.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Saint Louis University School of Medicine, St. Louis, Missouri, USA.
- Department of Internal Medicine, Division of Cardiology, SSM Health Saint Louis University Hospital, St. Louis, Missouri, USA.
- Division of Cardiothoracic Surgery, Department of Surgery, SSM Health Saint Louis University Hospital, St. Louis, Missouri, USA.
ORCID profiles: Rohit B Ponnada, Atharva M Bhagwat, Chien-Jung Lin
Funding
- American Heart Association
Cite
APA
Ponnada, R. B., Shah, A. K., Pujari, B., Bhagwat, A. M., Marrero-Rivera, L., Golemi, L., Arora, S., Verma, D. R., Le, A. T., Maniar, H., & Lin, C. J. (2026). Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease. Catheterization and Cardiovascular Interventions, 107(6), 1966-1969. https://doi.org/10.1002/ccd.70566
Vancouver
Ponnada RB, Shah AK, Pujari B, Bhagwat AM, Marrero-Rivera L, Golemi L, et al. Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease. Catheterization and Cardiovascular Interventions. 2026;107(6):1966-1969. doi:10.1002/ccd.70566
BibTeX
@article{Ponnada2026,
author = {Ponnada, Rohit B and Shah, Atman K and Pujari, Bhanuteja and Bhagwat, Atharva M and Marrero-Rivera, Ladislao and Golemi, Lolita and Arora, Shilpkumar and Verma, Divya Ratan and Le, Anh-Thu and Maniar, Hersh and Lin, Chien-Jung},
title = {Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {107},
number = {6},
pages = {1966--1969},
doi = {10.1002/ccd.70566}
}
EUVIMED